Who Paid My Doc
Miranda Foust
Clinical Nurse Specialist, Psychiatric/Mental Health Happy Valley, OR Clinical Nurse Specialist
NPI 1386812329 CMS profile 10418849
11211 Se 82Nd Ave Ste O, Happy Valley, OR 97086
General payments
$78
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Miranda Foust of Happy Valley, OR is reported in the CMS Open Payments database as having received $78 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 22nd percentile of Clinical Nurse Specialist, Psychiatric/Mental Health profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $78 | 1 |
Beside peers
- Miranda Foust
- Clinical Nurse Specialist, Psychiatric/Mental Health median
- Middle half of Clinical Nurse Specialist, Psychiatric/Mental Health
- National median
In program year 2025, general payments to Miranda Foust were reported at $78. Among 300 Clinical Nurse Specialist, Psychiatric/Mental Health profiles paid that year, the median was $245 and the middle half received between $78 and $929.
Show as a table
| Year | Miranda Foust | Clinical Nurse Specialist, Psychiatric/Mental Health median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | — | — | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $0 | $153 | $44–$540 | $132 |
| 2022 | $0 | $207 | $60–$748 | $149 |
| 2023 | $0 | $197 | $55–$898 | $160 |
| 2024 | $0 | $189 | $49–$804 | $164 |
| 2025 | $78 | $245 | $78–$929 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 14 drugsPart D claims
220
Drug cost
$58,671
Branded share of claims
10.9%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Invega Sustenna Paliperidone Palmitate | Brand | 12 | $40,502 | |
| Geodon Ziprasidone Hcl | Brand | 12 | $13,511 | |
| Perphenazine | Generic | 13 | $906 | |
| Chlorpromazine Hcl | Generic | 14 | $805 | |
| Atomoxetine Hcl | Generic | 14 | $616 | |
| Olanzapine | Generic | 24 | $477 | |
| Gabapentin | Generic | 16 | $347 | |
| Clonazepam | Generic | 20 | $337 | |
| Hydroxyzine Pamoate | Generic | 22 | $295 | |
| Trazodone Hcl | Generic | 20 | $241 |
The 10 drugs with the highest cost, of 14 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,644 Part D prescribers listed as Certified Clinical Nurse Specialist; they describe a distribution and say nothing about conduct.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Clinical Nurse Specialist, Psychiatric/Mental Health in Oregon
Sarah Grosse
Clinical Nurse Specialist, Psychiatric/Mental Health · La Pine, OR
Megan Sorensen
Clinical Nurse Specialist, Psychiatric/Mental Health · Corvallis, OR
James Devaney
Clinical Nurse Specialist, Psychiatric/Mental Health · Eugene, OR
Kara Del Curto
Clinical Nurse Specialist, Psychiatric/Mental Health · Baker City, OR
Mary King
Clinical Nurse Specialist, Psychiatric/Mental Health · Portland, OR
Related records
Clinical Nurse Specialist, Psychiatric/Mental Health in Oregon
Practitioners in the same specialty and state, ranked by reported value.
All Clinical Nurse Specialist, Psychiatric/Mental Health
Everyone recorded under this specialty, nationwide.
Doctors in Oregon
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.